Safety of the nipple-sparing mastectomy in treating breast cancer

doi:10.3760/cma.j.issn.1673-422X.2017.01.013

Journal of International Oncology ›› 2017, Vol. 44 ›› Issue (1): 49-52.doi: 10.3760/cma.j.issn.1673-422X.2017.01.013

Previous Articles Next Articles

Safety of the nipple-sparing mastectomy in treating breast cancer

Li Wenbin, Tang Han, Zou Jieya, Wang Xiaoqi, Nie Jianyun

Department of Second Breast Surgery, Third Affiliated Hospital of Kunming Medical University, Kunming 650118, China

Online:2017-01-08 Published:2016-12-07
Contact: Nie Jianyun, Email: njyvip@sina.com E-mail:njyvip@sina.com

Abstract

Abstract: As a kind of breast cancer surgery choice, the nipple-sparing mastectomy (NSM) saves the patients′ nipple-areola complex (NAC) which has significant meaning for patients′ cosmetic results and postoperation reconstruction. However, the clinical application of NSM is still in controversial. Some hot topics about oncological safety of NSM have appeared in recent years, such as the screening criterion of the enrolled patients, the situation of NAC involvement and the complications after NSM and handing methods.

Key words: Breast cancer, Safety, Nipple-sparing mastectomy

Li Wenbin, Tang Han, Zou Jieya, Wang Xiaoqi, Nie Jianyun. Safety of the nipple-sparing mastectomy in treating breast cancer[J]. Journal of International Oncology, 2017, 44(1): 49-52.

[1]	Shao Jianqiang, Wang Peng, Bai Jie, Li Huixin, Wang Zunyi, Xu Zhihong. The mechanism of extract of ginkgo biloba inducing mitochondrial autophagy in breast cancer cells MCF-7 [J]. Journal of International Oncology, 2024, 51(2): 65-72.
[2]	Li Bin, Zhang Guifang, Zhou Linjing, Yang Xiaodong, He Qiuli, Jia Sisi, Huang Puchao, Liang Jiaxin. Relationships between PIK3CA gene status and clinical features and prognosis in triple-negative breast cancer [J]. Journal of International Oncology, 2023, 50(5): 263-267.
[3]	Lu Jialing, Huang Huijuan, Liu Dan, Chen Yanxin, Ma Xiao, Wu Depei. Efficacy and safety of blinatumomab in the treatment of B-cell acute lymphoblastic leukemia [J]. Journal of International Oncology, 2022, 49(8): 494-498.
[4]	Gao Shan, Lu Minqiu, Shi Lei, Chu Bin, Fang Lijuan, Xiang Qiuqing, Wang Yutong, Ding Yuehua, Bao Li. Clinical efficacy and safety of ixazomib-based therapy in the treatment of relapsed or refractory multiple myeloma [J]. Journal of International Oncology, 2022, 49(5): 286-291.
[5]	Li Ling, Qin Li, Jiao Shuhong, Hao Chongli, Wang Wei, Zhang Fen, Zhang Kaiguo. Expression and its clinical significance of AIB1 protein in the tissues of ovarian carcinoma [J]. Journal of International Oncology, 2017, 44(12): 902-906.
[6]	Mao Li, Cui Caiping, Zhang Jing, Zhou Ping. Mechanism of breast cancer metastasis suppressor gene 1 inhibiting tumor metastasis [J]. Journal of International Oncology, 2016, 43(8): 619-621.
[7]	Pan Zhongya, Long Xinghua. Breast cancer metastasis suppressor gene 1 correlates with progression of cancer: a Metaanalysis [J]. Journal of International Oncology, 2016, 43(8): 603-608.
[8]	CHEN Shi-Fang, DU Cai-Wen. Research progress on bilateral breast cancer [J]. Journal of International Oncology, 2013, 40(3): 208-211.
[9]	FAN Jun-Qiu, FAN Jin-Man. Study of informing cancer patients of the disease with the optimized security strategy based on AQ score [J]. Journal of International Oncology, 2012, 39(8): 709-712.
[10]	WANG Lian. The role of amplified in breast family and their research mechanisms in ovarian cancer [J]. Journal of International Oncology, 2012, 39(6): 452-454.

Safety of the nipple-sparing mastectomy in treating breast cancer

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 10

Recommended Articles

Metrics

Comments